β-Glucan from Saccharomyces cerevisiae reduces lipopolysaccharide- induced inflammatory responses in RAW264.7 macrophages

Biochimica et Biophysica Acta - General Subjects

Volumn 1820, Issue 10, 2012, Pages 1656-1663

  Xu, Xiaojuan ^a,b   Yasuda, Michiko ^a   Mizuno, Masashi ^a   Ashida, Hitoshi ^a  

^a KOBE UNIVERSITY   (Japan)

^b WUHAN UNIVERSITY   (China)

Author keywords

Anti inflammation; Beta glucan; Inducible nitric oxide synthase; Lipopolysaccharide; RAW264.7 macrophage

Indexed keywords

BETA GLUCAN; DECTIN 1 ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 27; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOSYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; INFLAMMATION; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BETA-GLUCANS; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; SACCHAROMYCES CEREVISIAE;

FUNGI; SACCHAROMYCES CEREVISIAE;

EID: 84863750795     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2012.06.015     Document Type: Article

References (33)

1. P.M. Schwartsburd Chronic inflammation as inductor of pro-cancer microenvironment: pathogenesis of dysregulated feedback control Cancer Metastasis Rev. 22 2003 95 102
2. L.P. Cousens, J.S. Orange, H.C. Su, and C.A. Biron Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection Proc. Natl. Acad. Sci. U. S. A. 94 1997 634 639
3. K.M. Kopydlowski, C.A. Salkowski, M.J. Cody, N. van Rooijen, J. Major, and T.A. Hamilton Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo J. Immunol. 163 1999 1537 1544
4. L. Bingle, N.J. Brown, and C.E. Lewis The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies J. Pathol. 196 2002 254 265
5. A. Murakami Chemoprevention with phytochemicals targeting inducible nitric oxide synthase Forum Nutr. 61 2009 193 203
6. K.L. Davis, E. Martin, I.V. Turko, and F. Murad Novel effects of nitric oxide Annu. Rev. Pharmacol. Toxicol. 41 2001 203 236
7. P. Tripathi, P. Tripathi, L. Kashyap, and V. Singh The role of nitric oxide in inflammatory reactions FEMS Immunol. Med. Microbiol. 51 2007 443 452
8. J.B. Hibbs, Z. Vavrin, and R.R. Taintor l-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells J. Immunol. 138 1987 550 565
9. G.C. Brown Cell biology. NO says yes to mitochondria Science (New York, N.Y.) 299 2003 838 839
10. Y.-J. Surh Cancer chemoprevention with dietary phytochemicals Nat. Rev. Cancer 3 2003 768 780
11. S.V. Tsoni, and G.D. Brown Beta-glucans and dectin-1 Ann. N. Y. Acad. Sci. 1143 2008 45 60
12. J. Chen, and R. Seviour Medicinal importance of fungal beta-(1->3), (1->6)-glucans Mycol. Res. 111 2007 635 652
13. H.S. Goodridge, A.J. Wolf, and D.M. Underhill Beta-glucan recognition by the innate immune system Immunol. Rev. 230 2009 38 50
14. F. Lebron, R. Vassallo, V. Puri, and A.H. Limper Pneumocystis carinii cell wall beta-glucans initiate macrophage inflammatory responses through NF-kappaB activation J. Biol. Chem. 278 2003 25001 25008
15. A. Sandvik, Y.Y. Wang, H.C. Morton, A.O. Aasen, J.E. Wang, and F.-E. Johansen Oral and systemic administration of beta-glucan protects against lipopolysaccharide-induced shock and organ injury in rats Clin. Exp. Immunol. 148 2007 168 177
16. X. Xu, C. Pan, L. Zhang, and H. Ashida Immunomodulatory β-glucan from Lentinus edodes activates mitogen-activated protein kinases and nuclear factor-κB in murine RAW 264.7 macrophages J. Biol. Chem. 286 2011 31194 31198
17. A. Takahashi, N. Yamamoto, and A. Murakami Cardamonin suppresses nitric oxide production via blocking the IFN-γ/STAT pathway in endotoxin-challenged peritoneal macrophages of ICR mice Life Sci. 89 2011 337 342
18. G.D. Brown, and S. Gordon Immune recognition of fungal beta-glucans Cell. Microbiol. 7 2005 471 479
19. U. Förstermann, and H. Kleinert Nitric oxide synthase: expression and expressional control of the three isoforms Naunyn Schmiedebergs Arch. Pharmacol. 352 1995 351 364
20. Y.-H. Kim, S.-H. Lee, J.-Y. Lee, S.-W. Choi, J.-W. Park, and T.K. Kwon Triptolide inhibits murine-inducible nitric oxide synthase expression by down-regulating lipopolysaccharide-induced activity of nuclear factor-kappa B and c-Jun NH2-terminal kinase Eur. J. Pharmacol. 494 2004 1 9
21. G.D. Ross Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/alphaMbeta2-integrin glycoprotein Crit. Rev. Immunol. 20 2000 197 222
22. B.N. Gantner, R.M. Simmons, S.J. Canavera, S. Akira, and D.M. Underhill Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2 J. Exp. Med. 197 2003 1107 1117
23. H.S. Goodridge, C.N. Reyes, C.A. Becker, T.R. Katsumoto, J. Ma, and A.J. Wolf Activation of the innate immune receptor Dectin-1 upon formation of a phagocytic synapse Nature 472 2011 471 475
24. S.-H. Choi, R. Harkewicz, J.H. Lee, A. Boullier, F. Almazan, and A.C. Li Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake Circ. Res. 104 2009 1355 1363
25. D.C. Rockey, J.J. Chung, C.M. McKee, and P.W. Noble Stimulation of inducible nitric oxide synthase in rat liver by hyaluronan fragments Hepatology (Baltimore, Md.) 27 1998 86 92
26. D.A. Geller, C.J. Lowenstein, R.A. Shapiro, A.K. Nussler, M. Di Silvio, and S.C. Wang Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes Proc. Natl. Acad. Sci. U. S. A. 90 1993 3491 3495
27. N.R. Bhat, P. Zhang, J.C. Lee, and E.L. Hogan Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures J. Neurosci. 18 1998 1633 1641
28. Q.W. Xie, Y. Kashiwabara, and C. Nathan Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase J. Biol. Chem. 269 1994 4705 4708
29. P. Puddu, M. Carollo, I. Pietraforte, F. Spadaro, M. Tombesi, and C. Ramoni IL-2 induces expression and secretion of IFN-gamma in murine peritoneal macrophages J. Leukoc. Biol. 78 2005 686 695
30. V. Toshchakov, B.W. Jones, P.-Y. Perera, K. Thomas, M.J. Cody, and S. Zhang TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages Nat. Immunol. 3 2002 392 398
31. X. Xu, M. Yasuda, S. Nakamura-Tsuruta, M. Mizuno, and H. Ashida β-Glucan from Lentinus edodes inhibits nitric oxide and tumor necrosis factor-α production and phosphorylation of mitogen-activated protein kinases in lipopolysaccharide-stimulated murine RAW 264.7 macrophages J. Biol. Chem. 287 2012 871 878
32. A. Moltó, and A. Olivé Anti-IL-1 molecules: new comers and new indications Joint Bone Spine 77 2010 102 107
33. M. Jankowski, P. Kopiński, and A. Goc Interleukin-27: biological properties and clinical application Arch. Immunol. Ther. Exp. 58 2010 417 425